MAECON performs a variety of medication adherence related projects including (pharmaco)epidemiological studies, usability studies, bioanalytical studies, educational and awareness programs, intervention development programs to randomised clinical trials of interventions and digital devices, of which a selection is showcased below. Funding comes from both private and public sources.
Digital inhalers are currently being assessed in clinical studies and some have recently been introduced on the market. Indeed, digital inhalers could help in management
Recently, an electronic version of the Dosepak® (EDP) has been developed to monitor adherence to tablets, pills or capsules. It consists of a customizable blister
To be most effective, interventions focusing on enhancing adherence should be evidence-based and provided in a personalized manner. To identify personal issues with adherence in
A novel smart pill bottle may support patients’ adherence. This new bottle is connected with a smartphone app, allowing the user to receive reminders when
In 2020, MAECON was awarded a 4-year grant from the European Commission to set up and chair a COST Action on medication adherence. This European
Many patients with asthma and/or COPD are dependent on inhalers to administer their medication. These devices are however difficult to use and require optimal inhaler
MAECON combines multidisciplinary adherence expertise with complementary knowledge